Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Intimation for Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 ,inter alia, to consider and approve (i) audited financial statements/annual financial results for the financial year ended on March 31, 2022; and (ii) recommendation of final dividend, if any, for financial year 2021-22.
11-05-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
28-04-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for financial year 2021-22
20-04-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sandeep PhadnisDesignation :- Company Secretary and Compliance Officer
14-04-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliance Certificate Under Regulation 7(3) For The Year Ended March 31, 2022

 Compliance certificate under regulation 7(3) for the year ended March 31, 2022
14-04-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Issue of duplicate share certificate
13-04-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

 Update on Assignment of Trademark for Azmarda(r) indicated for heart failure patients with reduced ejection fraction (HfrEF) from Novartis AG, Switzerland for India
12-04-2022

KKR-backed JB Chemicals bets big on lozenges and probiotic products

 JB Chemicals now plan to enter new areas like sleep disorders, sexual wellness, motion sickness, and immunity apart, from the conventional areas like cough, sore throat, etc.
02-04-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Assignment Of Trademark For Azmarda(r) Indicated For Heart Failure Patients With Reduced Ejection Fraction (Hfref) From Novartis AG, Switzerland For India

 Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
01-04-2022
Bigul

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Closure of Trading Window

 Closure of Trading Window
31-03-2022
Next Page
Close

Let's Open Free Demat Account